Philipp M. Lepper
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Philipp M. Lepper has a total of 46 co-authors. Here are the top co-authors by number of shared publications:
Kathy Triantafilou
Department of Child Health, School of Medicine, University Hospital of Wales, Cardiff University, Cardiff CF14 4XN, UK
3 shared publicationsMartha Triantafilou
Department of Child Health, School of Medicine, University Hospital of Wales, Cardiff University, Cardiff CF14 4XN, UK; Infection and Immunity Group, School of Life Sciences, University of Sussex, Falmer, Brighton BN1 9QG, UK
3 shared publications- Christian Schumann
Department of Internal Medicine II; University of Ulm; Ulm, Germany
2 shared publications Jukka Takala
Laboratory of Intensive Care, Department of Clinical Research, University of Bern, Bern, Switzerland
2 shared publicationsSiamak Djafarzadeh
Laboratory of Intensive Care, Department of Clinical Research, University of Bern, Bern, Switzerland
2 shared publicationsTomas Regueira
Laboratory of Intensive Care, Department of Clinical Research, University of Bern, Bern, Switzerland
2 shared publications
Latest Publications
- 1 March 2012
- Published by Taylor & Francis in Virulence
- Vol. 3 (2) , 136-145
Serum proteins modulate lipopolysaccharide and lipoteichoic acid-induced activation and contribute to the clinical outcome of sepsis
Bacterial cell wall components, such LPS and LTA, are potent initiators of an inflammatory response that can lead to septic shock. The advances in the past were centered around membrane-bound receptors and intracellular events, but our understanding of the initial interactions of these bacterial components with serum proteins as they enter the bloodstream remain unclear. In this study we identified several serum proteins, which are involved in the innate recognition of bacterial products. Using affinity chromatography and mass spectrometry we performed proteomic analysis of LPS- and LTA-binding serum proteins. We isolated proteins from normal serum that can interact with LPS and LTA. Fluorescent binding experiments and cytokine assays revealed that serum proteins, such as apolipoprotein, LDL, transferrin and holotransferrin could neutralize LPS/LTA binding as well as the subsequent inflammatory response, suggesting that serum proteins modulate LPS/LTA-induced responses. When compared with the proteomic profile of serum from septic patients it was shown that these proteins were in lower abundance. Investigation of serum proteins in 25 critically ill patients with a mortality rate of 40% showed statistically higher levels of these proteins in survivors. Patients surviving sepsis had statistically significant higher levels of apolipoprotein, albumin, LDL, transferrin and holotransferrin than individuals that succumbed, suggesting that these proteins have an inhibitory effect on LPS/LTA-induced inflammatory responses and in their absence there might be an augmented inflammatory response in sepsis.
- 1 March 2012
- Published by Taylor & Francis in Virulence
- Vol. 3 (2) , 136-145
Serum proteins modulate lipopolysaccharide and lipoteichoic acid-induced activation and contribute to the clinical outcome of sepsis
Bacterial cell wall components, such LPS and LTA, are potent initiators of an inflammatory response that can lead to septic shock. The advances in the past were centered around membrane-bound receptors and intracellular events, but our understanding of the initial interactions of these bacterial components with serum proteins as they enter the bloodstream remain unclear. In this study we identified several serum proteins, which are involved in the innate recognition of bacterial products. Using affinity chromatography and mass spectrometry we performed proteomic analysis of LPS- and LTA-binding serum proteins. We isolated proteins from normal serum that can interact with LPS and LTA. Fluorescent binding experiments and cytokine assays revealed that serum proteins, such as apolipoprotein, LDL, transferrin and holotransferrin could neutralize LPS/LTA binding as well as the subsequent inflammatory response, suggesting that serum proteins modulate LPS/LTA-induced responses. When compared with the proteomic profile of serum from septic patients it was shown that these proteins were in lower abundance. Investigation of serum proteins in 25 critically ill patients with a mortality rate of 40% showed statistically higher levels of these proteins in survivors. Patients surviving sepsis had statistically significant higher levels of apolipoprotein, albumin, LDL, transferrin and holotransferrin than individuals that succumbed, suggesting that these proteins have an inhibitory effect on LPS/LTA-induced inflammatory responses and in their absence there might be an augmented inflammatory response in sepsis.
- Open Access
- 21 June 2011
- Published by Wiley in Mediators of Inflammation
- Vol. 2011, 1-10
Location, Location, Location: Is Membrane Partitioning Everything When It Comes to Innate Immune Activation?
In the last twenty years, the general view of the plasma membrane has changed from a homogeneous arrangement of lipids to a mosaic of microdomains. It is currently thought that islands of highly ordered saturated lipids and cholesterol, which are laterally mobile, exist in the plane of the plasma membrane. Lipid rafts are thought to provide a means to explain the spatial segregation of certain signalling pathways emanating from the cell surface. They seem to provide the necessary microenvironment in order for certain specialised signalling events to take place, such as the innate immune recognition. The innate immune system seems to employ germ-lined encoded receptors, called pattern recognition receptors (PRRs), in order to detect pathogens. One family of such receptors are the Toll-like receptors (TLRs), which are the central “sensing” apparatus of the innate immune system. In recent years, it has become apparent that TLRs are recruited into membrane microdomains in response to ligands. These nanoscale assemblies of sphingolipid, cholesterol, and TLRs stabilize and coalesce, forming signalling platforms, which transduce signals that lead to innate immune activation. In the current paper, we will investigate all past and current literature concerning recruitment of extracellular and intracellular TLRs into lipid rafts and how this membrane organization modulates innate immune responses.
- 21 June 2011
- Published by Wiley in Mediators of Inflammation
- Vol. 2011, 1-10
Open AccessLocation, Location, Location: Is Membrane Partitioning Everything When It Comes to Innate Immune Activation?
In the last twenty years, the general view of the plasma membrane has changed from a homogeneous arrangement of lipids to a mosaic of microdomains. It is currently thought that islands of highly ordered saturated lipids and cholesterol, which are laterally mobile, exist in the plane of the plasma membrane. Lipid rafts are thought to provide a means to explain the spatial segregation of certain signalling pathways emanating from the cell surface. They seem to provide the necessary microenvironment in order for certain specialised signalling events to take place, such as the innate immune recognition. The innate immune system seems to employ germ-lined encoded receptors, called pattern recognition receptors (PRRs), in order to detect pathogens. One family of such receptors are the Toll-like receptors (TLRs), which are the central “sensing” apparatus of the innate immune system. In recent years, it has become apparent that TLRs are recruited into membrane microdomains in response to ligands. These nanoscale assemblies of sphingolipid, cholesterol, and TLRs stabilize and coalesce, forming signalling platforms, which transduce signals that lead to innate immune activation. In the current paper, we will investigate all past and current literature concerning recruitment of extracellular and intracellular TLRs into lipid rafts and how this membrane organization modulates innate immune responses.
- 27 January 2011
- Published by SAGE Publications in Respiratory Care
- Vol. 56 (5) , 653-666
Superior Vena Cava Syndrome in Thoracic Malignancies
The superior vena cava syndrome (SVCS) comprises various symptoms due to occlusion of the SVC, which can be easily obstructed by pathological conditions (eg, lung cancer, due to the low internal venous pressure within rigid structures of the thorax [trachea, right bronchus, aorta]). The resulting increased venous pressure in the upper body may cause edema of the head, neck, and upper extremities, often associated with cyanosis, plethora, and distended subcutaneous vessels. Despite the often striking clinical presentation, SVCS itself is usually not a life-threatening condition. Currently, randomized controlled trials on many clinically important aspects of SVCS are lacking. This review gives an interdisciplinary overview of the pathophysiology, etiology, clinical manifestations, diagnosis, and treatment of malignant SVCS.
- 27 January 2011
- Published by SAGE Publications in Respiratory Care
- Vol. 56 (5) , 653-666
Superior Vena Cava Syndrome in Thoracic Malignancies
The superior vena cava syndrome (SVCS) comprises various symptoms due to occlusion of the SVC, which can be easily obstructed by pathological conditions (eg, lung cancer, due to the low internal venous pressure within rigid structures of the thorax [trachea, right bronchus, aorta]). The resulting increased venous pressure in the upper body may cause edema of the head, neck, and upper extremities, often associated with cyanosis, plethora, and distended subcutaneous vessels. Despite the often striking clinical presentation, SVCS itself is usually not a life-threatening condition. Currently, randomized controlled trials on many clinically important aspects of SVCS are lacking. This review gives an interdisciplinary overview of the pathophysiology, etiology, clinical manifestations, diagnosis, and treatment of malignant SVCS.
- 31 August 2010
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 140 (2) , 488
Reply to the Editor
- 31 August 2010
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 140 (2) , 488
Reply to the Editor
- Open Access
- 7 June 2010
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 5 (6) , e10983
Effects of TLR Agonists on the Hypoxia-Regulated Transcription Factor HIF-1α and Dendritic Cell Maturation under Normoxic Conditions
Dendritic cells (DC) are professional antigen presenting cells that represent an important link between innate and adaptive immunity. Danger signals such as toll-like receptor (TLR) agonists induce maturation of DC leading to a T-cell mediated adaptive immune response. In this study, we show that exogenous as well as endogenous inflammatory stimuli for TLR4 and TLR2 induce the expression of HIF-1α in human monocyte-derived DC under normoxic conditions. On the functional level, inhibition of HIF-1α using chetomin (CTM), YC-1 and digoxin lead to no consistent effect on MoDC maturation, or cytokine secretion despite having the common effect of blocking HIF-1α stabilization or activity through different mechanisms. Stabilization of HIF-1α protein by hypoxia or CoCl2 did not result in maturation of human DC. In addition, we could show that TLR stimulation resulted in an increase of HIF-1α controlled VEGF secretion. These results show that stimulation of human MoDC with exogenous as well as endogenous TLR agonists induces the expression of HIF-1α in a time-dependent manner. Hypoxia alone does not induce maturation of DC, but is able to augment maturation after TLR ligation. Current evidence suggests that different target genes may be affected by HIF-1α under normoxic conditions with physiological roles that differ from those induced by hypoxia.
- 7 June 2010
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 5 (6) , e10983
Open AccessEffects of TLR Agonists on the Hypoxia-Regulated Transcription Factor HIF-1α and Dendritic Cell Maturation under Normoxic Conditions
Dendritic cells (DC) are professional antigen presenting cells that represent an important link between innate and adaptive immunity. Danger signals such as toll-like receptor (TLR) agonists induce maturation of DC leading to a T-cell mediated adaptive immune response. In this study, we show that exogenous as well as endogenous inflammatory stimuli for TLR4 and TLR2 induce the expression of HIF-1α in human monocyte-derived DC under normoxic conditions. On the functional level, inhibition of HIF-1α using chetomin (CTM), YC-1 and digoxin lead to no consistent effect on MoDC maturation, or cytokine secretion despite having the common effect of blocking HIF-1α stabilization or activity through different mechanisms. Stabilization of HIF-1α protein by hypoxia or CoCl2 did not result in maturation of human DC. In addition, we could show that TLR stimulation resulted in an increase of HIF-1α controlled VEGF secretion. These results show that stimulation of human MoDC with exogenous as well as endogenous TLR agonists induces the expression of HIF-1α in a time-dependent manner. Hypoxia alone does not induce maturation of DC, but is able to augment maturation after TLR ligation. Current evidence suggests that different target genes may be affected by HIF-1α under normoxic conditions with physiological roles that differ from those induced by hypoxia.
- Open Access
- 1 January 2010
- Published by Wiley in Mediators of Inflammation
- Vol. 2010, 1-2
Modulation of Toll-Like Receptor Signalling as a New Therapeutic Principle
- 1 January 2010
- Published by Wiley in Mediators of Inflammation
- Vol. 2010, 1-2
Open AccessModulation of Toll-Like Receptor Signalling as a New Therapeutic Principle
- 1 October 2009
- Published by Wiley in Liver International
- Vol. 29 (10) , 1582-1592
Hypoxia inducible factor‐1α induction by tumour necrosis factor‐α, but not by toll‐like receptor agonists, modulates cellular respiration in cultured human hepatocytes
Background/Aims: Genes encoding for some of the mitochondrial proteins are under the control of the transcriptional factor hypoxia inducible factor‐1α (HIF‐1α), which can accumulate under normoxic conditions in inflammatory states. The aim of this study was to evaluate the effects of cobalt chloride (CoCl2, a hypoxia mimicking agent), tumour necrosis factor‐α (TNF‐α) and toll‐like receptor (TLR) ‐2, ‐3 and ‐4 agonists on HIF‐1α accumulation, and further on HIF‐1α‐mediated modulation of mitochondrial respiration in cultured human hepatocytes.Methods: The human hepatoma cell line HepG2 was used in this study. Cells were treated with CoCl2, TNF‐α and TLR‐2, ‐3 and ‐4 agonists. HIF‐1α was determined by Western blotting and mitochondrial respiration in stimulated cells by high‐resolution respirometry.Results: CoCl2, TNF‐α and TLR agonists induced the expression of HIF‐1α in a time‐dependent fashion. TNF‐α and CoCl2, but not TLR agonists, induced a reduction in complex I‐, II‐ and IV‐dependent mitochondrial oxygen consumption. TNF‐α‐associated reduction of cellular oxygen consumption was abolished through inhibition of HIF‐1α activity by chetomin (CTM). Pretreatment with cyclosporine A prevented CoCl2‐induced reduction of complex I‐ and II‐dependent mitochondrial oxygen consumption and TNF‐α‐induced reduction of complex‐I‐dependent respiration, implicating the involvement of the mitochondrial permeability transition pore openings. TNF‐α and TLR‐2, ‐3 and ‐4 agonists induced the expression of vascular endothelial growth factor, which was partially abolished by the blockage of HIF‐1α with CTM.Conclusions: The data suggest that HIF‐1α modulates mitochondrial respiration during CoCl2 and TNF‐α stimulation, whereas it has no effect when induced with TLR‐2, ‐3 and ‐4 agonists.
- 1 October 2009
- Published by Wiley in Liver International
- Vol. 29 (10) , 1582-1592
Hypoxia inducible factor‐1α induction by tumour necrosis factor‐α, but not by toll‐like receptor agonists, modulates cellular respiration in cultured human hepatocytes
Background/Aims: Genes encoding for some of the mitochondrial proteins are under the control of the transcriptional factor hypoxia inducible factor‐1α (HIF‐1α), which can accumulate under normoxic conditions in inflammatory states. The aim of this study was to evaluate the effects of cobalt chloride (CoCl2, a hypoxia mimicking agent), tumour necrosis factor‐α (TNF‐α) and toll‐like receptor (TLR) ‐2, ‐3 and ‐4 agonists on HIF‐1α accumulation, and further on HIF‐1α‐mediated modulation of mitochondrial respiration in cultured human hepatocytes.Methods: The human hepatoma cell line HepG2 was used in this study. Cells were treated with CoCl2, TNF‐α and TLR‐2, ‐3 and ‐4 agonists. HIF‐1α was determined by Western blotting and mitochondrial respiration in stimulated cells by high‐resolution respirometry.Results: CoCl2, TNF‐α and TLR agonists induced the expression of HIF‐1α in a time‐dependent fashion. TNF‐α and CoCl2, but not TLR agonists, induced a reduction in complex I‐, II‐ and IV‐dependent mitochondrial oxygen consumption. TNF‐α‐associated reduction of cellular oxygen consumption was abolished through inhibition of HIF‐1α activity by chetomin (CTM). Pretreatment with cyclosporine A prevented CoCl2‐induced reduction of complex I‐ and II‐dependent mitochondrial oxygen consumption and TNF‐α‐induced reduction of complex‐I‐dependent respiration, implicating the involvement of the mitochondrial permeability transition pore openings. TNF‐α and TLR‐2, ‐3 and ‐4 agonists induced the expression of vascular endothelial growth factor, which was partially abolished by the blockage of HIF‐1α with CTM.Conclusions: The data suggest that HIF‐1α modulates mitochondrial respiration during CoCl2 and TNF‐α stimulation, whereas it has no effect when induced with TLR‐2, ‐3 and ‐4 agonists.
- Open Access
- 1 January 2006
- Published by Wiley in Mediators of Inflammation
- Vol. 2006 (1) , 18061
Detection of Erythropoietin in Exhaled Breath Condensate of Nonhypoxic Subjects Using a Multiplex Bead Array
As a noninvasive method, exhaled breath condensate (EBC) has gained importance to improve monitoring of lung diseases and to detect biomarkers. The aim of the study was to investigate, whether erythropoietin (EPO) is detectable in EBC. EBC was collected from 22 consecutive patients as well as from healthy individuals. Using a multiplex fluorescent bead immunoassay, we detected EPO in EBC, as well as tumour necrosis factor‐α (TNF‐α) in 13 out of 22 patients simultaneously (EPO 0.21 ± 0.03 in U/mL and TNF‐α 34.6 ± 4.2 in pg/mL, mean ± SEM). No significant differences for EPO levels or correlation between EPO and TNF‐α were found but TNF‐α was significantly higher in patients with chronic obstructive pulmonary disease (COPD) than in non‐COPD (obstructive sleep apnoea, OSA, and lung healthy patients). This is the first report of detection of EPO in EBC. Due to the small study size more data is needed to clarify the role of EPO in EBC.
- 1 January 2006
- Published by Wiley in Mediators of Inflammation
- Vol. 2006 (1) , 18061
Open AccessDetection of Erythropoietin in Exhaled Breath Condensate of Nonhypoxic Subjects Using a Multiplex Bead Array
As a noninvasive method, exhaled breath condensate (EBC) has gained importance to improve monitoring of lung diseases and to detect biomarkers. The aim of the study was to investigate, whether erythropoietin (EPO) is detectable in EBC. EBC was collected from 22 consecutive patients as well as from healthy individuals. Using a multiplex fluorescent bead immunoassay, we detected EPO in EBC, as well as tumour necrosis factor‐α (TNF‐α) in 13 out of 22 patients simultaneously (EPO 0.21 ± 0.03 in U/mL and TNF‐α 34.6 ± 4.2 in pg/mL, mean ± SEM). No significant differences for EPO levels or correlation between EPO and TNF‐α were found but TNF‐α was significantly higher in patients with chronic obstructive pulmonary disease (COPD) than in non‐COPD (obstructive sleep apnoea, OSA, and lung healthy patients). This is the first report of detection of EPO in EBC. Due to the small study size more data is needed to clarify the role of EPO in EBC.